| Pharmaceutical active ingredients: |
| Ranibizumab |
| Available forms, composition and doses of Lucentis: |
| Injectable; Injection; Ranibizumab 10 mg / ml |
| Lucentis medical category: |
| Human:Age-related macular degeneration (ARMD) treatment drugsMonoclonal antibodies |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01LA04 - Ranibizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GenentechAgencia Lei Va HongNovartisZuellig Pharma |
| Related documents and information about Lucentis: |
| Lucentis prescribing information (PDF) |